Source: European Medicines Agency (EU) Revision Year: 2026 Publisher: UCB Pharma SA, Allée de la Recherche 60, B-1070 Brussels, Belgium
Keppra 100 mg/ml oral solution.
| Pharmaceutical Form |
|---|
|
Oral solution. Clear liquid. |
Each ml contains 100 mg levetiracetam
Excipients with known effect: Each ml contains 2.7 mg of methyl parahydroxybenzoate (E218), 0.3 mg of propyl parahydroxybenzoate (E216) and 300 mg of maltitol liquid.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Levetiracetam, is a pyrrolidone derivative, chemically unrelated to existing antiepileptic active substances. Levetiracetam induces seizure protection in a broad range of animal models of partial and primary generalised seizures without having a pro-convulsant effect. The primary metabolite is inactive. |
| List of Excipients |
|---|
|
Sodium citrate |
300 ml amber glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 10 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene).
150 ml amber glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 5 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene).
150 ml amber glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 1 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene).
UCB Pharma SA, Allée de la Recherche 60, B-1070 Brussels, Belgium
EU/1/00/146/027
EU/1/00/146/031
EU/1/00/146/032
Date of first authorisation: 29 September 2000
Date of latest renewal: 20 August 2015
| Drug | Countries | |
|---|---|---|
| KEPPRA | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.